AAV Standards Full Capsids
The field of gene therapy is in great need for well characterized AAV reference standards. Recombinant adeno-associated virus (rAAV) is a widely used gene delivery tool for research and clinical applications. Per January 2020 FDA’s gene therapy CMC guidance, commercially sourced, well-characterized AAV reference standards are one of the reference standards for gene therapy. Vigene’s AAV reference standards (full capsids) with accurate vector genome concentration can be used in qPCR-based vector genome quantification. Additionly Vigene’s AAV reference standards are well characterized for full-to-empty capsid ratio. We can provide AAV reference standards in AAV1, AAV2, AAV5, AAV6, AAV8 and AAV9 serotypes.